STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Short Interest Update

Posted by Maddie Sorensen on Nov 17th, 2024

STRATA Skin Sciences, Inc. (NASDAQ:SSKN – Get Free Report) was the recipient of a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 5,500 shares, a growth of 48.6% from the October 15th total of 3,700 shares. Approximately 0.2% of the company’s stock are sold short. Based on an average daily trading volume, of 12,500 shares, the short-interest ratio is presently 0.4 days.

Institutional Investors Weigh In On STRATA Skin Sciences

An institutional investor recently bought a new position in STRATA Skin Sciences stock. Azzad Asset Management Inc. ADV acquired a new stake in STRATA Skin Sciences, Inc. (NASDAQ:SSKN – Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 12,000 shares of the medical device company’s stock, valued at approximately $33,000. Azzad Asset Management Inc. ADV owned approximately 0.34% of STRATA Skin Sciences at the end of the most recent reporting period. 32.43% of the stock is currently owned by institutional investors and hedge funds.

STRATA Skin Sciences Stock Down 2.9 %

SSKN traded down $0.09 on Friday, hitting $3.01. 5,058 shares of the company were exchanged, compared to its average volume of 12,246. The stock’s fifty day moving average is $3.01 and its 200-day moving average is $3.23. The company has a market cap of $12.55 million, a PE ratio of -1.13 and a beta of 1.32. The company has a debt-to-equity ratio of 1.59, a quick ratio of 0.92 and a current ratio of 1.14. STRATA Skin Sciences has a 12 month low of $2.51 and a 12 month high of $6.96.

STRATA Skin Sciences (NASDAQ:SSKN – Get Free Report) last released its quarterly earnings results on Wednesday, August 14th. The medical device company reported ($0.03) earnings per share for the quarter. STRATA Skin Sciences had a negative net margin of 28.72% and a negative return on equity of 67.36%. The company had revenue of $8.44 million during the quarter. Equities research analysts predict that STRATA Skin Sciences will post -1 EPS for the current fiscal year.

STRATA Skin Sciences Company Profile

(Get Free Report)

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.